BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/26/2019 3:39:24 AM | Browse: 1244 | Download: 3361
Publication Name World Journal of Hepatology
Manuscript ID 44984
Country Brazil
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model
Manuscript Source Invited Manuscript
All Author List Francielle Graus-Nunes, Felipe de Oliveira Santos, Thatiany de Souza Marinho, Carolline Santos Miranda, Sandra Barbosa-da-Silva and Vanessa Souza-Mello
ORCID
Author(s) ORCID Number
Francielle Graus-Nunes http://orcid.org/0000-0002-6212-3116
Felipe de Oliveira Santos http://orcid.org/0000-0003-4693-2682
Thatiany de Souza Marinho http://orcid.org/0000-0001-9976-9466
Carolline Santos Miranda http://orcid.org/0000-0001-5488-0179
Sandra Barbosa-da-Silva http://orcid.org/0000-0003-3866-0912
Vanessa Souza-Mello http://orcid.org/0000-0002-2510-9569
Funding Agency and Grant Number
Funding Agency Grant Number
Fundação Carlos Chagas Filho de Apoio à Pesquisa do Estado do Rio de Janeiro (FAPERJ E-26/202.888/2015
Corresponding Author Vanessa Souza-Mello, PhD, Adjunct Professor, Laboratório de Morfometria, Metabolismo e Doenças Cardiovasculares, Departamento de Anatomia, Instituto de Biologia Roberto Alcântara Gomes, Av. 28 de setembro 87 fundos, Rio de Janeiro 20551-030, Brazil. v.souzamello@gmail.com
Key Words Liver; Telmisartan; Losartan; Obesity; Angiotensin II type 1 receptor; C57BL/6 mouse
Core Tip Studies that address the modulation of local renin-angiotensin system (RAS) have gathered pace as it was established that obese subjects exhibit overexpression of the components of classical RAS in organs like the liver. Herein we show pieces of evidence that two different angiotensin II receptor blockers can modulate the intrahepatic RAS, with favored angiotensin-converting enzyme (ACE) 2/rMAS axis over ACE1/angiotensin II type 1 receptor in mice fed a high-fat diet. These actions could mitigate hepatic steatosis through reduced hepatic triacylglycerol levels along with decreased body mass and better glycemic control. These drugs could be a viable option to treat non-alcoholic fatty liver disease in obese and/or hypertensive patients.
Publish Date 2019-04-26 03:39
Citation Graus-Nunes F, Santos FO, Marinho TS, Miranda CS, Barbosa-da-Silva S, Souza-Mello V. Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model. World J Hepatol 2019; 11(4): 359-369
URL https://www.wjgnet.com/1948-5182/full/v11/i4/359.htm
DOI https://dx.doi.org/10.4254/wjh.v11.i4.359
Full Article (PDF) WJH-11-359.pdf
Full Article (Word) WJH-11-359.docx